Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MN › Minneapolis › NPI 1366589962
Clinic

University of Minnesota Physicians

University of Minnesota Physicians was paid $5.94M by Medicaid between Jan 2018 and Dec 2024, across 94 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 59% of everything it billed.

33Billing provider infoUNIVERSITY OF MINNESOTA PHYSICIANS
MINNEAPOLIS, MN 55411
33aNPI1366589962assigned 01/31/2007
28Total paid$5.94M
24GClaims187,365
24DCodes billed94
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Primary Care Clinic/Center providers in Minnesota

Rank by total paid#5 of 72
Median peer was paid$251K
This provider vs. median24×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201850,879$434K
201940,598$1.37M
202023,522$800K
202126,885$1.01M
202217,483$790K
202315,941$800K
2024incomplete12,057$743K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 59% 51,281 42,499 $3.52M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 12% 14,805 13,332 $698K
99000 3.0% 8,061 7,503 $177K
80306 2.5% 12,242 9,317 $149K
S0302 Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) 2.4% 3,725 3,535 $145K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2.1% 4,163 3,999 $124K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2.1% 4,165 4,002 $124K
X5622 1.9% 6,458 5,117 $111K
99442 1.5% 1,819 1,561 $91K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1.1% 6,641 6,349 $67K
36415 Collection of venous blood by venipuncture <1% 16,433 14,589 $54K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 923 892 $54K
82 more codes
87808 <1% 3,913 $46K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 825 $46K
99441 <1% 1,334 $41K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 717 $38K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 644 $36K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,580 $34K
90472 Immunization administration, each additional vaccine (list separately) <1% 2,671 $34K
80048 Basic metabolic panel (calcium, ionized) <1% 4,109 $27K
T1013 Sign language or oral interpretive services, per 15 minutes <1% 816 $22K
86780 <1% 1,798 $21K
87210 <1% 4,411 $20K
S0281 Medical home program, comprehensive care coordination and planning, maintenance of plan <1% 933 $20K
83036 Hemoglobin; glycosylated (A1C) <1% 2,561 $19K
81025 <1% 2,688 $17K
99443 <1% 285 $16K
90832 Psychotherapy session, about 30 minutes <1% 300 $16K
92551 <1% 2,898 $15K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 236 $15K
99203 Doctor's office visit, new patient (routine) <1% 331 $15K
80061 Lipid panel <1% 1,389 $14K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,525 $12K
84443 Thyroid stimulating hormone (TSH) <1% 799 $11K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 1,623 $11K
90686 <1% 1,400 $10K
99215 Doctor's office visit, returning patient (complex) <1% 84 $6K
90834 Psychotherapy session, about 45 minutes <1% 77 $6K
99188 <1% 720 $5K
36416 <1% 1,544 $4K
80053 Comprehensive metabolic panel <1% 452 $4K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 235 $4K
99173 <1% 2,830 $3K
90715 <1% 421 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 288 $3K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 35 $3K
85018 <1% 1,284 $2K
90670 <1% 862 $2K
82947 <1% 804 $2K
96127 <1% 540 $2K
90651 <1% 228 $2K
90688 <1% 231 $2K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 438 $1K
0064A <1% 38 $1K
81001 <1% 498 $1K
86803 <1% 86 $1K
87086 Culture, bacterial; quantitative colony count, urine <1% 283 $1K
87081 <1% 257 $1K
81003 <1% 847 $1K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 25 $1K
83655 <1% 180 $1K
90656 <1% 79 $1K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 12 $791.91
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 21 $601.44
85027 <1% 143 $510.53
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 70 $503.16
96161 <1% 416 $499.23
0011A <1% 12 $490.09
90480 <1% 12 $448.62
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 12 $403.30
97802 <1% 16 $335.09
82043 <1% 81 $303.87
90473 <1% 75 $288.72
G0008 Administration of influenza virus vaccine <1% 84 $276.56
93000 <1% 38 $249.05
90734 <1% 194 $241.24
0001A <1% 32 $174.96
0002A <1% 15 $121.28
99383 <1% 16 $110.66
90648 <1% 762 $0.52
90633 <1% 355 $0.41
90723 <1% 512 $0.29
90710 <1% 190 $0.25
90696 0% 31 $0.00
90716 0% 106 $0.00
98967 0% 14 $0.00
90732 0% 14 $0.00
99384 0% 12 $0.00
90681 0% 95 $0.00
90700 0% 13 $0.00
90707 0% 89 $0.00
98968 0% 24 $0.00
90713 0% 12 $0.00
90685 0% 19 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSIBERT, WILLIAM (CFO)
Same official

Other billing entities under SIBERT, WILLIAM

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.